National Guidelines for HIV Prevention Treatment and Care - Nigeria, 2016
(2016; 250 pages)


The National Guidelines for HIV Prevention Treatment and Care is a ten-chapter document that provides general and specific guidance for the prevention and treatment of HIV Infection using a broad range of interventions:

Chapter one is the introduction of the guidelines and its focus is on the guiding principles for the guidelines, the process of guidelines review and the epidemiology of HIV/AIDS in Nigeria, while chapter two provides guidance on the HIV testing services and laboratory and clinical diagnosis of HIV infection.

Chapter three deals with the use of ART in treatment of HIV disease with emphasis on the characteristics and mechanism of action of ARVs, criteria for initiation of ART in different age groups, the approved regimens for ART and management of treatment failure. Chapter four recognizes the need to track and manage adverse drug reactions and provides guidance for effective pharmacovigilance in ART.

In chapter five the focus is on adherence to antiretroviral therapy and the factors that limit or enhance its achievement while chapter six is dedicated to the prevention of mother to child transmission of HIV using ART and non-ART interventions for preventing mother to child transmission of HIV including prophylaxis for the HIV exposed infant.

Chapter Seven is the preventive management of HIV/AIDS providing detailed guidance for offer of PrEP and PEP. Chapter Eight is focused on the management of opportunistic infections and comorbidities and provides guidance on a broad range of subjects such as Cotrimoxazole Preventive Therapy, IPT and TB co-infection and the management of common opportunistic infections.

The focus of Chapter Nine is on improving efficiency of service delivery through innovative models such as differentiated care, decentralization of services, logistics management and linkage to care among other recommendations.

Chapter Ten deals with monitoring of services and provides basic information on the strategies for monitoring implementation of HIV/AIDS services under these guidelines.

The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018